Latest | F'cast | |
---|---|---|
Div Yield | 5.7% | 0.0% |
Div Cover | 1.4 | 0.4 |
Op Mrgn | 3.1% | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | 12.3 | 28.5 |
PEG | n/a | n/a |
Pr/Revenue | 0.4 | 0.8 |
Pr/Book | 3.1 |
Latest | F'cast | |
---|---|---|
Revenue | 84.4% | -50.7% |
PBT | -10.2% | -100.0% |
EPS | -7.3% | -56.7% |
DPS | n/a | 67.9% |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Jun-20 | 52.10 | 4.70 | 3.20p | 10.3 | n/a | -3% | 4.45p | 13.5% |
30-Jun-21 | 214.70 | 5.10 | 3.60p | 16.0 | 1.3 | +12% | 4.45p | 7.7% |
30-Jun-22 | (53.70) | 3.80 | 2.60p | 16.5 | n/a | -28% | 2.65p | 6.2% |
30-Jun-23 | 91.70 | 5.90 | 4.10p | 11.2 | 0.2 | +58% | 2.65p | 5.8% |
30-Jun-24 | 169.10 | 5.30 | 3.80p | 12.1 | n/a | -7% | 2.65p | 5.8% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Jun-25 | 83.37 | n/a | 1.64p | 28.5 | n/a | -57% | 4.45p | 0.0% |
30-Jun-26 | 91.42 | n/a | 3.12p | 15.0 | 0.2 | +90% | 4.45p | 0.0% |
Copyright © 2024 FactSet Research Systems Inc. All rights reserved.
Result of AGM | 13-Nov-2024 | 12:00 | RNS |
Block listing Interim Review | 22-Oct-2024 | 07:00 | RNS |
Appointment of Chief Financial Officer | 02-Oct-2024 | 07:00 | RNS |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 46.90p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 53.50 |
52 Week Low | 39.60 |
Volume | 1,000 |
Shares Issued | 137.56m |
Market Cap | £64.51m |
Beta | 0.16 |
RiskGrade | 154 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 0 |
Buy | 1 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
Latest | Previous | |
---|---|---|
Final | Interim | |
Ex-Div | 03-Oct-24 | 14-Mar-24 |
Paid | 14-Nov-24 | 25-Apr-24 |
Amount | 2.65p | 1.80p |
Time | Volume / Share Price |
09:14 | 1,000 @ 45.11p |
Chair | Philip Kay |
CEO | Thomas Morfett |
You are here: research